Changes of activated circulating endothelial cells and survivin in patients with non-small cell lung cancer after antiangiogenesis therapy
Lists
Only you see this
Abstract
Activated CECs and survivin may be ideal markers forecasting efficacy and prognosis of NSCLC. The former can reflect more sensitively antiangiogenic efficacy and the latter is more sensitive to shrinkage or swelling of tumors. Their combination can evaluate more accurately the efficacy of antiangiogenic therapy of NSCLC.
BibTeX
@inproceedings{wang2008changes,
author = {Jing Wang and Chun Huang and Xi-yin WEI and Da-liang QI and Li-qun GONG and Hai-yu MU and Qiang Yao and Kai Li},
title = {{Changes of activated circulating endothelial cells and survivin in patients with non-small cell lung cancer after antiangiogenesis therapy}},
booktitle = {Chinese},
year = {2008},
doi = {10.1097/00029330-200811020-00005},
}Loading related content...